Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Blank, C.U.
  • (-) ≠ Bresser, K.
  • (-) = Kelderman, S.

Search results

  • RSS Feed
(1 - 3 of 3)
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Kelderman, S.; Heemskerk, B.; Tinteren, H. van; Brom, R.R.H. van den; Hospers, G.A.P.; Eertwegh, A.J.M. van den; ... ; Blank, C.U. 2014
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Article / Letter to editor
metadata only
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)
Kelderman, S.; Kooij, M.K. van der; Eertwegh, A.J.M. van den; Soetekouw, P.M.M.B.; Jansen, R.L.H.; Brom, R.R.H. van den; ... ; Blank, C.U. 2013
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)
Article / Letter to editor
metadata only
Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma
Blank, C.U.; Kelderman, S.; Tinteren, H. van; Heemskerk, B.; Brom, R. van den; Hospers, G.A.; ... ; Larkin, J.M.G. 2013
Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma
Article / Letter to editor
metadata only